Ouro Fino Saúde Animal Participações S.A - Asset Resilience Ratio
Ouro Fino Saúde Animal Participações S.A (OFSA3) has an Asset Resilience Ratio of 10.18% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See OFSA3 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2011–2024)
This chart shows how Ouro Fino Saúde Animal Participações S.A's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Ouro Fino Saúde Animal Participações S.A asset portfolio.
Liquid Assets Composition Over Time
This chart breaks down Ouro Fino Saúde Animal Participações S.A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Ouro Fino Saúde Animal Participações S.A (OFSA3) long-term investment share to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | R$135.15 Million | 10.18% |
| Short-term Investments | R$0.00 | 0% |
| Total Liquid Assets | R$135.15 Million | 10.18% |
Asset Resilience Insights
- Moderate Liquidity: Ouro Fino Saúde Animal Participações S.A has 10.18% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Ouro Fino Saúde Animal Participações S.A Industry Peers by Asset Resilience Ratio
Compare Ouro Fino Saúde Animal Participações S.A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Beijing Tongrentang Co Ltd
SHG:600085 |
Drug Manufacturers - Specialty & Generic | 0.50% |
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Neuland Laboratories Limited
NSE:NEULANDLAB |
Drug Manufacturers - Specialty & Generic | 9.65% |
|
China Resources Double-Crane Pharmaceutical Co Ltd
SHG:600062 |
Drug Manufacturers - Specialty & Generic | 1.18% |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267 |
Drug Manufacturers - Specialty & Generic | 0.01% |
Annual Asset Resilience Ratio for Ouro Fino Saúde Animal Participações S.A (2011–2024)
The table below shows the annual Asset Resilience Ratio data for Ouro Fino Saúde Animal Participações S.A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 16.12% | R$223.26 Million ≈ $43.81 Million |
R$1.38 Billion ≈ $271.70 Million |
-6.56pp |
| 2023-12-31 | 22.68% | R$290.13 Million ≈ $56.93 Million |
R$1.28 Billion ≈ $250.96 Million |
+11.48pp |
| 2022-12-31 | 11.21% | R$150.92 Million ≈ $29.61 Million |
R$1.35 Billion ≈ $264.21 Million |
-14.45pp |
| 2021-12-31 | 25.66% | R$305.99 Million ≈ $60.04 Million |
R$1.19 Billion ≈ $234.02 Million |
+4.27pp |
| 2020-12-31 | 21.38% | R$236.04 Million ≈ $46.32 Million |
R$1.10 Billion ≈ $216.61 Million |
+12.61pp |
| 2019-12-31 | 8.78% | R$76.32 Million ≈ $14.97 Million |
R$869.54 Million ≈ $170.62 Million |
-4.94pp |
| 2018-12-31 | 13.71% | R$116.02 Million ≈ $22.77 Million |
R$846.01 Million ≈ $166.00 Million |
-13.35pp |
| 2017-12-31 | 27.07% | R$219.31 Million ≈ $43.03 Million |
R$810.23 Million ≈ $158.98 Million |
+10.02pp |
| 2016-12-31 | 17.04% | R$132.19 Million ≈ $25.94 Million |
R$775.58 Million ≈ $152.18 Million |
+17.04pp |
| 2015-12-31 | 0.00% | R$22.00K ≈ $4.32K |
R$693.37 Million ≈ $136.05 Million |
-1.65pp |
| 2014-12-31 | 1.65% | R$10.38 Million ≈ $2.04 Million |
R$627.26 Million ≈ $123.08 Million |
+1.10pp |
| 2013-12-31 | 0.55% | R$2.98 Million ≈ $585.12K |
R$538.68 Million ≈ $105.70 Million |
+0.36pp |
| 2012-12-31 | 0.20% | R$887.00K ≈ $174.05K |
R$452.13 Million ≈ $88.72 Million |
+0.18pp |
| 2011-12-31 | 0.02% | R$88.00K ≈ $17.27K |
R$465.91 Million ≈ $91.42 Million |
-- |
About Ouro Fino Saúde Animal Participações S.A
Ouro Fino Saúde Animal Participações S.A., together with its subsidiaries, engages in the development, production, and sale of veterinary drugs, vaccines, and other products for production and companion animals primarily in Brazil. The company operates through three segments: Production Animals; Companion Animals; and International Operations. It manufactures and trades in medicines, including an… Read more